A number of ASX 200 shares are making their shareholders smile today after rising to record highs.
Let's take a look at a selection that are scaling new heights today. They are as follows:
Brambles Ltd (ASX: BXB)
The Brambles share price has hit a record high of $19.25 this morning. This brings the logistics solutions company's 12-month gain to a sizeable 36%.
In August, the ASX 200 share impressed the market with its full year results. It posted an 8% increase in sales revenue and a 19% jump in operating profit after tax. It also guided to underlying profit growth of 8% to 11% in FY 2025.
Hub24 Ltd (ASX: HUB)
The Hub24 share price has touched on a new all-time high of $62.69 on Wednesday. This means the investment platform provider's shares are now up 90% since this time last year.
The catalyst for this has been its strong performance in FY 2024. In addition, the company was recently added to the ASX 100 index. This may have driven demand for its shares from index funds and fund managers with certain investment mandates.
Netwealth Group Ltd (ASX: NWL)
The Netwealth share price has reached a record high of $26.85 today. Like Hub24, it is an investment platform provider that has delivered big returns for shareholders over the past 12 months. Since this time last year, Netwealth's shares have now climbed 85%.
Investors have been buying the ASX 200 share this year after it delivered another strong performance in FY 2024. The company reported a 25.2% increase in funds under administration and a 24.1% lift in net profit after tax to $83.4 million.
Pinnacle Investment Management Group Ltd (ASX: PNI)
The Pinnacle share price has hit a new record high of $19.01 on Wednesday. The investment management company's shares are now up 120% since this time last year.
A strong performance in FY 2024 has helped drive its shares higher. It reported a 7.6% lift in revenue and an 18.1% jump in net profit after tax.
Pro Medicus Limited (ASX: PME)
The Pro Medicus share price has continued its remarkable run and reached a new all-time high of $184.84. This means the ASX 200 share is up 122% in the space of a year.
Earlier this week, the health imaging technology company announced yet another major contract win. It advised that St Louis based Mercy Health has committed to an eight-year term with a minimum value of $98 million over the period.
CEO, Dr Sam Hupert, notes that the "industry norm for renewals is for short extensions to the original contract at the same or lower price."
However, he points out that "Mercy has renewed for a longer contract term and at an increased price." Dr Hupert believes this shows confidence in its offering and reinforces its belief that "the Visage solution delivers unparalleled value in terms of both financial and clinical ROI."
